HIV/AIDS Diagnostics
P24 antigen accurately monitors HAART in pediatric HIV-1 infection
Published in TB and Outbreaks Week, June 13th, 2006
"Worldwide, 700,000 infants are infected annually by HIV-1, most of them in resource-limited settings. Care for these children requires simple, inexpensive tests," investigators in Switzerland report.
According to M.W. Brinkhof and colleagues at the University of Zurich, "We have evaluated HIV-1 p24 antigen for antiretroviral treatment (ART) monitoring in children. p24 by boosted enzyme-linked immunosorbent assay of heated plasma and HIV-1 RNA were measured prospectively in 24 HIV-1-infected children receiving ART.
"p24 and HIV-1 RNA concentrations and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diabetes & Tuberculosis
Diabetes is a risk factor for tuberculosis - Gonorrhea Epidemiology
Prolyliminopeptidase-negative N. gonorrhoeae strains followed an epidemic growth curve - Melioidosis Outbreaks
Extreme weather events associated with melioidosis case-clusters in Australia - Norovirus Outbreaks
Major shift of predominant norovirus strain coincided with new variant of genogroup II4 - Vibrio Cholerae
Toxigenic Vibrio cholerae detected in aquatic environment in Bangladesh - Antimicrobial Drug Development
Passifloricin analogues have antimalarial and antimycobacterial activity - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
